Reports

The global 5% Sodium Chloride Hypertonic Ophthalmic Solution market was valued at 113 million in 2025 and is projected to reach US$ 187 million by 2032, at a CAGR of 7.6% during the forecast period.

The global Sodium Chloride Hypertonic Ophthalmic 5% market was valued at 141 million in 2025 and is projected to reach US$ 234 million by 2032, at a CAGR of 7.6% during the forecast period.

The global 5% Sodium Chloride Eye Drops market was valued at 113 million in 2025 and is projected to reach US$ 187 million by 2032, at a CAGR of 7.6% during the forecast period.

The global Injected Veterinary Pain Management Drugs market was valued at 2959 million in 2025 and is projected to reach US$ 5712 million by 2032, at a CAGR of 10.0% during the forecast period.

The global Artificial Blood Substitute market was valued at 12.94 million in 2025 and is projected to reach US$ 45.51 million by 2032, at a CAGR of 19.1% during the forecast period.

The global Polymyxin B market was valued at 51.69 million in 2025 and is projected to reach US$ 44.17 million by 2032, at a CAGR of -2.3% during the forecast period.

The global PSA Test market was valued at 580 million in 2025 and is projected to reach US$ 1009 million by 2032, at a CAGR of 8.4% during the forecast period.

The global Plant-based Protein Powders market was valued at 6017 million in 2025 and is projected to reach US$ 9381 million by 2032, at a CAGR of 6.7% during the forecast period.

The global Biologics and Biosimilars market was valued at 434490 million in 2025 and is projected to reach US$ 803020 million by 2032, at a CAGR of 9.4% during the forecast period.

The global Medicinal Sugar Sphere market was valued at 158 million in 2025 and is projected to reach US$ 245 million by 2032, at a CAGR of 6.7% during the forecast period.